HTG MOLECULAR DIAGNOSTICS, INC
DelistedCIK 1169987fmd_1B4QRT68AXKBHRCD8JZ8Z0VPK5Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2014 to Mar 31, 2023, 37 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 3 | 4 | 5 | 15 | 22 | 19 | 9 | 9 | 6 |
| Cost of revenue | 3 | 3 | 4 | 5 | 5 | 9 | 4 | 4 | 5 |
| Gross profit | 0 | 1 | 1 | 10 | 16 | 10 | 5 | 5 | 2 |
| Research and development | 3 | 5 | 8 | 10 | 13 | 11 | 6 | 6 | 7 |
| Selling, general and administrative | 10 | 15 | 17 | 18 | 20 | 19 | 18 | 17 | 16 |
| Total operating expenses | 13 | 20 | 25 | 28 | – | – | – | – | – |
| Operating income | (13) | (19) | (24) | (18) | (16) | (19) | (20) | (18) | (21) |
| Interest expense | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income (expense) | (1) | (2) | (2) | (1) | (0) | (0) | (1) | 1 | (1) |
| Income before taxes | (14) | (21) | (26) | (19) | (16) | (19) | (21) | (17) | (22) |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | (21) | (26) | (19) | (16) | (19) | (21) | (17) | (22) |
| Net income | (14) | (21) | (26) | (19) | (16) | (19) | (21) | (17) | (22) |
| Net income to common shareholders | (18) | (23) | (26) | – | – | – | – | – | – |